MEMO-Medical Marijuana and Opioids Study

Completed

Conditions studied: Opioid Use, Marijuana, Chronic Pain, HIV/AIDS

In brief

The study will examine how medical cannabis use affects opioid analgesic use over time, with particular attention to THC/CBD content, HIV outcomes, and severe adverse events.

Key facts

Study ID

NCT03268551

Run by

Albert Einstein College of Medicine

People needed

257

Starts

2018-09-04

Expected to finish

2023-07-14

Last updated by the study team

2023-11-08

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• At least 18 years of age
• English or Spanish fluency
• New certification for medical cannabis within 90 days
• No medical cannabis use in the 6 months prior to certification
• Medical cannabis qualifying complication of "chronic or severe pain"
• Use of prescribed or illicit opioid analgesics within 30 days

You may not qualify if…

• Inability to provide informed consent
• Inability to complete study visits over 18 months
• Qualifying conditions for medical cannabis in NY that are likely to cause unique pain syndromes (cancer, epilepsy, multiple sclerosis, spinal cord injury, amyotrophic lateral sclerosis, Parkinson's disease, inflammatory bowel disease, Hungtington's disease)
• Terminal illness
• Current or prior psychotic disorder

Where it is running

• Montefiore Health System — The Bronx, New York, United States
• Vireo Health — White Plains, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.